My 6 Favorite HeadaTerm 2 Features

My 6 Favorite HeadaTerm 2 Features

Cerebral Torque

HeadaTerm 2: FDA-Cleared Migraine Relief for less than $80

Use code: CEREBRALTORQUE for 20% OFF!
Get HeadaTerm 2 Now

Uses the same eTNS technology as Cefaly® - at less than 1/3 the price!

27% more effective than oral migraine medications - without side effects

Use code: CEREBRALTORQUE for 20% OFF!
 Get Your HeadaTerm 2 Today
Back to blog
  • My 6 Favorite HeadaTerm 2 Features

    My 6 Favorite HeadaTerm 2 Features

    Cerebral Torque

    HeadaTerm 2: FDA-Cleared Migraine Relief for less than $80 Use code: CEREBRALTORQUE for 20% OFF! Get HeadaTerm 2 Now Your browser does not support the video tag. Uses the same eTNS technology...

    My 6 Favorite HeadaTerm 2 Features

    Cerebral Torque

    HeadaTerm 2: FDA-Cleared Migraine Relief for less than $80 Use code: CEREBRALTORQUE for 20% OFF! Get HeadaTerm 2 Now Your browser does not support the video tag. Uses the same eTNS technology...

  • The Two Migraine Pathophysiology Theories

    Cerebral Torque

    Migraine Pathophysiology Theories

    The Two Migraine Pathophysiology Theories

    Cerebral Torque

    Migraine Pathophysiology Theories

  • Cortical Spreading Depression Video Study Guide

    Cortical Spreading Depression Video Study Guide

    Cerebral Torque

    (Scroll down for video) Important Concepts: Definition of Cortical Spreading Depression (CSD): A wave of neuronal and glial depolarization that slowly progresses across the cerebral cortex. Role in Migraine: CSD...

    Cortical Spreading Depression Video Study Guide

    Cerebral Torque

    (Scroll down for video) Important Concepts: Definition of Cortical Spreading Depression (CSD): A wave of neuronal and glial depolarization that slowly progresses across the cerebral cortex. Role in Migraine: CSD...

  • A Breakthrough on the Horizon: PACAP-Targeting Antibodies Offer New Promise for Migraine Prevention

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

    A Breakthrough on the Horizon: PACAP-Targeting ...

    Cerebral Torque

    Migraine patients may soon have a new treatment option. Recent clinical trials show promising results for Lu AG09222, a monoclonal antibody targeting PACAP, a neuropeptide involved in migraine pathophysiology.

1 4
View all